Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

Clinical trial NCT00427908 · COMPLETED

Trial details

NCT number: NCT00427908
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infections, Meningococcal

Start date: 2007-02-07
Primary completion: 2007-12-03
Enrollment: 613

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.